What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

The introduction of imatinib to clinical practice revolutionized therapy of advanced gastrointestinal stromal tumors (GIST), but its long-term results have been only just collected. We have attempted to identify factors related to the long-term survival. We have analyzed the data of 430 inoperable/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Andrzejuk, Jolanta, Bylina, Elżbieta, Osuch, Czesław, Świtaj, Tomasz, Jerzak vel Dobosz, Anna, Grzesiakowska, Urszula, Jurkowska, Monika, Woźniak, Agnieszka, Limon, Janusz, Dębiec-Rychter, Maria, Siedlecki, Janusz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840282/
https://www.ncbi.nlm.nih.gov/pubmed/24217870
http://dx.doi.org/10.1007/s12032-013-0765-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840282/
https://www.ncbi.nlm.nih.gov/pubmed/24217870
http://dx.doi.org/10.1007/s12032-013-0765-7

Ejemplares similares